Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)

View source ↗

Summary

FDA approved a supplemental application for Sodium Polystyrene Sulfonate from Sunrise Pharmaceutical, Inc., resulting in an approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)